Science ❯ Biotechnology ❯ Drug Development

Clinical Research

Phase 3 Trials Gene Therapy Cancer Treatment Therapeutic Proteins Phase 1 Trials Therapeutic Effects AI Applications in Medicine FDA-Approved Drugs Midstage Trials Innovations Biomarker Testing Innovative Therapies Seizure Medications Oncology

5 ARTICLES

last mo.

Takeda Signs $600 Million‑Value AI Drug Discovery Deal With Insilico

The agreement signals Takeda's move toward an AI‑native discovery model by channeling Insilico's generative Pharma.AI into its clinical development pipeline.

3 ARTICLES

3mo ago

Altimmune Targets Second-Half 2026 Launch for Global Phase 3 MASH Trial

6 ARTICLES

7mo ago

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

7 ARTICLES

8mo ago

Wave Life Sciences Soars on Obesity Trial Signal as It Begins $250 Million Stock Offering

3 ARTICLES

9mo ago

myTomorrows Raises $29 Million From Avego to Scale AI Platform for Pre-Approval Treatments

6 ARTICLES

last yr.

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research